EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Ascl1 in Retinal Regeneration: From Neuronal Fate Determination to Reprogramming Mechanisms

Lin Yan, Bin Sun, Ni Li, Yuehan Yang, Huan Qin, Kai Yao iD

The FASEB Journal · 2025

DOI: 10.1096/fj.202502591r ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift The FASEB Journal, 2025. Verfasst von Lin Yan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Visual Neuroscience and Stem Cell Engineering, Wuhan University of Science and Technology, Wuhan, China. Hauptthemen laut MEDLINE: Basic Helix-Loop-Helix Proteins, Retina, Cellular Reprogramming, Nerve Regeneration. Die Arbeit nennt 161 Literaturangaben. Gefördert von: MOST | National Natural Science Foundation of China (NSFC), MOST | National Key Research and Development Program of China (NKPs), | Natural Science Foundation of Hubei Province ().

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ascl1 has emerged as a key transcription factor of interest in regenerative medicine due to its critical role in retinal neurogenesis and its therapeutic potential in neurological disorders. In lower vertebrates, such as zebrafish, retinal injury induces rapid expression of Ascl1a, enabling Müller glial cells to acquire stem cell‐like properties and regenerate retinal neurons. In contrast, mammalian Müller glia do not spontaneously express Ascl1 following injury and lack the capacity for neuronal reprogramming. Exogenous expression of Ascl1 enables the reprogramming of mammalian Müller glia and fibroblasts into functional retinal neurons, underscoring its therapeutic potential in the context of retinal neurodegeneration. In this review, we present a comprehensive overview of Ascl1, focusing on its key role in retinal neuronal development, retinal regeneration, and therapeutic potential in neurodegenerative diseases. Furthermore, we provide a comprehensive overview of the mechanisms underlying Ascl1‐mediated retinal regeneration and its multiple regulatory factors, aiming to offer novel insights and a theoretical foundation for future therapeutic strategies targeting retinal neurodegeneration.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Basic Helix-Loop-Helix ProteinsRetinaCellular ReprogrammingNerve RegenerationRetinal NeuronsRegenerationAnimalsHumansNeurogenesisZebrafishEpendymoglial Cells

Stichwörter der Autor:innen

Ascl1Müller glianeuronal regenerationreprogrammingretinal development

Substanzen

Basic Helix-Loop-Helix ProteinsASCL1 protein, human

Autor:innen und Institutionen

  • Institute of Visual Neuroscience and Stem Cell Engineering, Wuhan University of Science and Technology, Wuhan, China.
  • College of Life Sciences and Health, Wuhan University of Science and Technology, Wuhan, China.

ORCID-Profile: Kai Yao

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • MOST | National Key Research and Development Program of China (NKPs)
  • | Natural Science Foundation of Hubei Province ()
  • Neuroscience Team Development Project of Wuhan University of Science and Technology
  • the Graduate Innovation and Entrepreneurship Foundation of Wuhan University of Science and Technology
  • National Natural Science Foundation of China
  • National Key Research and Development Program of China
  • Natural Science Foundation of Hubei Province

Zitieren

APA

Yan, L., Sun, B., Li, N., Yang, Y., Qin, H., & Yao, K. (2025). Ascl1 in Retinal Regeneration: From Neuronal Fate Determination to Reprogramming Mechanisms. The FASEB Journal. https://doi.org/10.1096/fj.202502591r

Vancouver

Yan L, Sun B, Li N, Yang Y, Qin H, Yao K. Ascl1 in Retinal Regeneration: From Neuronal Fate Determination to Reprogramming Mechanisms. The FASEB Journal. 2025. doi:10.1096/fj.202502591r

BibTeX
@article{Yan2025,
  author = {Yan, Lin and Sun, Bin and Li, Ni and Yang, Yuehan and Qin, Huan and Yao, Kai},
  title = {Ascl1 in Retinal Regeneration: From Neuronal Fate Determination to Reprogramming Mechanisms},
  journal = {The FASEB Journal},
  year = {2025},
  doi = {10.1096/fj.202502591r}
}
Kostenlos starten →